8 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... with Community-Acquired ... Pneumonia (CAP) ... fluoroquinolone #IDSA ... Management #Guidelines #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Toxic Megacolon, Shock ... post-ABx, but can ... be community-acquired ... IDSA 2021 CDI ... #infectiousdiseases
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... against Pneumocystis pneumonia ... difficile Infection (CDI ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Capnocytophaga
Pathogen: Capnocytophaga
 • 9 species, C. canimorsus responsible for the majority of infections
 • Gram-negative rod,
Incubation period is 1- ... malaise • Septic shock ... Meningitis (13%), Pneumonia ... Treatment: • 50% ... microbiology #zoonotic #infectiousdiseases
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
IDSA Recommendations ... Prevention and Treatment ... of Pneumocystis Pneumonia ... #Treatment #PCP ... HIVAIDS #management #pharmacology
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
exacerbations, community-acquired ... pneumonia, sinusitis ... Ceftriaxone for CAP ... Used for MAC treatment ... #Pharmacology #Antibiotics
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
IDSA Recommendations ... Anti-motility agents can ... : • The best treatment ... Microsporidiosis #IDSA ... infections #HIVAIDS #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Epidemiology: • F > M: 9:1 ... Antinuclear antibodies ≥ 1: ... Usual interstitial pneumonia ... Adenocarcinoma Treatment ... lubricants • Pharmacologic